Reuters Events: Pharma and Patient USA 2025

Memo

Clinical trials are caught in an evolutionary bottleneck. We've developed incredible technology: AI patient matching, digital endpoints, virtual monitoring, predictive analytics. But we're still running trials with 30-year-old assumptions-and the same recruitment and retention struggles. The result? Revolutionary tools producing evolutionary results. We say we're patient-centric, but our systems are still site-centric. We talk about patient experience, but our KPIs are still protocol-centric. We have the capability to transform trials, but instead we erode trust through a reliance on compliance. Patient-centricity isn't the next evolution - it's the breakthrough that unleashes everything else. When you design around diverse patient needs, recruitment accelerates, retention improves, trust deepens. Your technology transforms from expensive overhead to competitive advantage. Pharma and Patient USA 2025 shows you how: your data becomes more predictive, your AI more accurate, your trials more inclusive, representative and successful. This is the difference between companies that invest in innovation and innovative companies. Join us and 300 experts from patient centricity, clinical development and advocacy organizations to embed patient perspectives, needs, and experiences at the core of every decision, and unlock the full potential of clinical trials. URL:Tickets: https://go.evvnt.com/3156761-0?pid=5569 Date and Time: Monday, 17 November 2025 at 09:00 to Tuesday, 18 November 2025 at 17:00 Venue details: Convene 30 S 17th Street, 30 South 17th Street, Philadelphia, Pennsylvania, 19103, United States Category: Conferences | Science, Health and Medicine | Pharmaceuticals Prices:Pharma Pass: USD 1999.00,Solution Provider Pass: USD 3499.00